Patients with SLE have higher risk of cardiovascular events and mortality in comparison with controls with the same levels of traditional risk factors and intima- media measures, which is related to accumulated disease damage and antiphospholipid syndrome: a case-control study over 10 years
In this medfyle
SLICC and SLE-APS associated with CV risk.
This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.
Expert commentary
About this Medfyle
This Medfyle is provided as a service to healthcare professionals. It has been created from content originally published in the Lupus Science & Medicine, EULAR’s official journal, through an official agreement with BMJ.
The summary content was prepared by Marie Farrow for Medfyle, reviewed & approved by Ronald F. van Vollenhoven, MD, PhD, Amsterdam UMC and Amsterdam Rheumatology Center, Amsterdam, the Netherlands.
Original article:
Ajeganova S, Hafström I, Frostegård J. Patients with SLE have higher risk of cardiovascular events and mortality in comparison with controls with the same levels of traditional risk factors and intima-media measures, which is related to accumulated disease damage and antiphospholipid syndrome: a case–control study over 10 years. Lupus Science & Medicine 2021;8:e000454. doi: 10.1136/lupus-2020-000454
The authors of the original article had no part in the creation of the summary.
Copyright © 2020 BMJ Publishing Group Limited and Globalport (International) Limited. All rights reserved.
The summaries, expert commentaries and slides included in this Medfyle are co-owned by BMJ and GlobalPort (International) Limited. The original journal article is an exclusive copyright of BMJ Publishing Group Limited.
